Richter Gedeon Vegyeszeti Gyar Nyrt
OTC:RGEDF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| HU |
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
|
1.9T HUF |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
954.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
546.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
268.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.9B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
265.4B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.6B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
94.4B EUR |
Loading...
|
Market Distribution
| Min | -47 953.1% |
| 30th Percentile | 6.7% |
| Median | 9.7% |
| 70th Percentile | 26% |
| Max | 9 465.3% |
Other Profitability Ratios
Richter Gedeon Vegyeszeti Gyar Nyrt
Glance View
Richter Gedeon Vegyeszeti Gyar Nyrt., popularly known as Gedeon Richter, traces its origins to 1901, when its founder, Gedeon Richter, established a modest pharmacy on the outskirts of Budapest. With a deep passion for innovation and a forward-thinking mindset, Richter transformed his small endeavor into Hungary's pioneering pharmaceutical company. Today, Gedeon Richter stands as a significant player in the global pharmaceutical industry, excelling in the research, development, manufacturing, and marketing of a wide array of medicinal products. The company's emphasis on in-house innovation and strategic collaborations has enabled it to carve a niche in the field of women's healthcare, biotechnology, and central nervous system therapies. The heart of Gedeon Richter's operations lies in its robust research and development capabilities. By investing heavily in scientific excellence, the company has developed a diversified portfolio that includes generic and specialty pharmaceuticals, as well as original research-driven products. The company generates revenue through a network that spans more than 100 countries, with a strong presence in Europe, the Commonwealth of Independent States, and the global markets at large. By keeping its manufacturing processes vertically integrated and maintaining a comprehensive distribution network, Gedeon Richter not only ensures efficiency and cost-effectiveness, but also consistently delivers quality products to both niche markets and mass consumers. This strategic focus on sustainable growth, combined with its commitment to providing innovative healthcare solutions, reflects the synergy of past legacy with future-focused aspirations.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Richter Gedeon Vegyeszeti Gyar Nyrt is 28.5%, which is above its 3-year median of 23.9%.
Over the last 3 years, Richter Gedeon Vegyeszeti Gyar Nyrt’s Operating Margin has increased from 25.7% to 28.5%. During this period, it reached a low of 17% on Sep 30, 2023 and a high of 28.5% on Sep 30, 2025.